T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dollar General
DG
|
+$1.37B |
| 2 |
Intel
INTC
|
+$1.28B |
| 3 |
SCHW
Charles Schwab
SCHW
|
+$1B |
| 4 |
Nike
NKE
|
+$859M |
| 5 |
Uber
UBER
|
+$825M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.67B |
| 2 |
Amazon
AMZN
|
+$2.15B |
| 3 |
NVIDIA
NVDA
|
+$1.64B |
| 4 |
Humana
HUM
|
+$1.57B |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$1.33B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.09% |
| 2 | Healthcare | 15.81% |
| 3 | Financials | 11.13% |
| 4 | Consumer Discretionary | 10.82% |
| 5 | Communication Services | 8.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
Phillips 66
PSX
$92.8B
| $194M | 0.03% |
1,454,649
+860,586
| +145% | +$103M |
|
427
IQVIA
IQV
$39.8B
| $191M | 0.03% |
826,869
-137,932
| -14% | -$28.3M |
|
428
Newmont
NEM
$120B
| $190M | 0.03% |
4,593,365
-3,181,475
| -41% | -$123M |
|
429
Air Products & Chemicals
APD
$68B
| $189M | 0.03% |
689,923
-35,430
| -5% | -$9.74M |
|
430
CAVA Group
CAVA
$8.43B
| $183M | 0.02% |
4,257,027
-1,064,899
| -20% | -$37.1M |
|
431
Ascendis Pharma A/S
ASND
$16.2B
| $182M | 0.02% |
1,444,950
-192,898
| -12% | -$19.2M |
|
432
Amcor
AMCR
$21.4B
| $179M | 0.02% |
3,703,492
+26,515
| +0.7% | +$1.22M |
|
433
ON Semiconductor
ON
$31.8B
| $178M | 0.02% |
2,129,852
-1,870,949
| -47% | -$147M |
|
434
Lattice Semiconductor
LSCC
$18.2B
| $177M | 0.02% |
2,569,311
+97,663
| +4% | +$6.49M |
|
435
RH
RH
$3.4B
| $176M | 0.02% |
603,185
+127,889
| +27% | +$33M |
|
436
Vornado Realty Trust
VNO
$7.41B
| $174M | 0.02% |
6,151,998
+62,681
| +1% | +$1.49M |
|
437
Assurant
AIZ
$13.9B
| $174M | 0.02% |
1,031,255
-48,119
| -4% | -$7.65M |
|
438
10x Genomics
TXG
$7.58B
| $174M | 0.02% |
3,104,174
+416,723
| +16% | +$18.1M |
|
439
UiPath
PATH
$8.64B
| $171M | 0.02% |
6,903,914
+3,076,247
| +80% | +$60M |
|
440
Vaxcyte
PCVX
$8.76B
| $168M | 0.02% |
2,677,822
+260,170
| +11% | +$13.5M |
|
|
SRCL
441
DELISTED
Stericycle Inc
SRCL
| $167M | 0.02% |
3,373,350
-447,939
| -12% | -$20.1M |
|
442
EastGroup Properties
EGP
$11B
| $166M | 0.02% |
903,836
-105,513
| -10% | -$18M |
|
443
Ultragenyx Pharmaceutical
RARE
$2.6B
| $165M | 0.02% |
3,448,698
+288,538
| +9% | +$11.2M |
|
444
Rockwell Automation
ROK
$49.5B
| $163M | 0.02% |
526,243
-5,689
| -1% | -$1.59M |
|
445
NOV
NOV
$7.36B
| $163M | 0.02% |
8,054,145
-1,355,891
| -14% | -$26.6M |
|
446
Verra Mobility
VRRM
$731M
| $163M | 0.02% |
7,075,833
+207,100
| +3% | +$4.25M |
|
447
Moody's
MCO
$84.6B
| $162M | 0.02% |
415,497
-227,772
| -35% | -$79.2M |
|
448
Teck Resources
TECK
$31.3B
| $162M | 0.02% |
3,838,695
-690,829
| -15% | -$26.5M |
|
449
Acadia Pharmaceuticals
ACAD
$4.89B
| $162M | 0.02% |
5,178,509
-51,652
| -1% | -$1.23M |
|
450
AerCap
AER
$23.5B
| $162M | 0.02% |
2,180,708
+13,502
| +0.6% | +$892K |
|
Similar funds
T. Rowe Price Associates's Q4 2023 Portfolio in Review
As of Q4 2023, T. Rowe Price Associates held 2,974 positions worth $744B, up 9.1% from $682B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
T. Rowe Price Associates's Q4 2023 filing shows 92 new, 1,834 increased, 805 reduced and 67 closed positions. Its largest new stake was Canadian Natural Resources: 6,473,658 shares worth $212M. The largest sale was Microsoft, an estimated $2.67B.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 30% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q4 2023 buy was Canadian Natural Resources: 6,473,658 shares worth $212M.
- T. Rowe Price Associates added most to Dollar General in Q4 2023, an estimated $1.37B increase.
- T. Rowe Price Associates's biggest Q4 2023 reduction was Microsoft, cutting an estimated $2.67B.
- T. Rowe Price Associates fully exited Activision Blizzard in Q4 2023, selling an estimated $293M.
- T. Rowe Price Associates's ten largest holdings make up 31% of its $744B portfolio in Q4 2023.
- T. Rowe Price Associates opened 92 new positions and closed 67 in Q4 2023.
- T. Rowe Price Associates's portfolio value rose 9.1% quarter-over-quarter to $744B.
Based on T. Rowe Price Associates's 13F filing for Q4 2023, filed 14 Feb 2024.